Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 New antiviral agents.

Literature DB >> 16816493

New antiviral agents.

Nahed Abdel-Haq¹, Pimpanada Chearskul, Hossam Al-Tatari, Basim Asmar.

Abstract

During the last three decades, a better understanding of viral replication and disease states caused by viral infections have led to the development of newer antiviral agents with enhanced activity and better tolerability. This review focuses on newer systemic and topical antiviral agents that are used in treatment of herpes viruses including herpes simplex type-1 (HSV-1) and type-2 (HSV-2), varicella-zoster virus (VZV) and cytomegalovirus CMV) as well as the human papilloma virus (HPV). Included in this article are the agents famciclovir, penciclovir, valganciclovir, imiquimod, docosanole and brivudin.

Entities: Chemical

Mesh：

Substances：

Year: 2006 PMID： 16816493 DOI： 10.1007/BF02825826

Source DB: PubMed Journal: Indian J Pediatr ISSN： 0019-5456 Impact factor: 5.319

74 in total

Review 1. Estimates of the incidence and prevalence of sexually transmitted diseases in the United States. American Social Health Association Panel.

Authors: W Cates
Journal: Sex Transm Dis Date: 1999-04 Impact factor: 2.830

2. Metabolic fate of (E)-5-(2-bromovinyl)-2'-deoxyuridine in herpes simplex virus- and mock-infected cells.

Authors: N K Ayisi; E De Clercq; R A Wall; H Hughes; S L Sacks
Journal: Antimicrob Agents Chemother Date: 1984-11 Impact factor: 5.191

3. Self-administered topical 5% imiquimod for the treatment of common warts and molluscum contagiosum.

Authors: U R Hengge; S Esser; T Schultewolter; C Behrendt; T Meyer; E Stockfleth; M Goos
Journal: Br J Dermatol Date: 2000-11 Impact factor: 9.302

4. Safety and efficacy of imiquimod 5% cream in the treatment of penile genital warts in uncircumcised men when applied three times weekly or once per day.

Authors: H Gollnick; R Barasso; U Jappe; K Ward; A Eul; M Carey-Yard; K Milde
Journal: Int J STD AIDS Date: 2001-01 Impact factor: 1.359

5. Pharmacokinetics of famciclovir in subjects with varying degrees of renal impairment.

Authors: S C Boike; M A Pue; M I Freed; P R Audet; A Fairless; B E Ilson; N Zariffa; D K Jorkasky
Journal: Clin Pharmacol Ther Date: 1994-04 Impact factor: 6.875

6. Pharmacokinetics of famciclovir in subjects with chronic hepatic disease.

Authors: S C Boike; M Pue; P R Audet; M I Freed; A Fairless; B E Ilson; N Zariffa; D K Jorkasky
Journal: J Clin Pharmacol Date: 1994-12 Impact factor: 3.126

7. Pharmacokinetics of valganciclovir and ganciclovir in renal impairment.

Authors: David Czock; Cornelia Scholle; Franz Maximilian Rasche; Dieter Schaarschmidt; Frieder Keller
Journal: Clin Pharmacol Ther Date: 2002-08 Impact factor: 6.875

8. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group.

Authors: F X Bosch; M M Manos; N Muñoz; M Sherman; A M Jansen; J Peto; M H Schiffman; V Moreno; R Kurman; K V Shah
Journal: J Natl Cancer Inst Date: 1995-06-07 Impact factor: 13.506

9. Famciclovir for the treatment of acute herpes zoster: effects on acute disease and postherpetic neuralgia. A randomized, double-blind, placebo-controlled trial. Collaborative Famciclovir Herpes Zoster Study Group.

Authors: S Tyring; R A Barbarash; J E Nahlik; A Cunningham; J Marley; M Heng; T Jones; T Rea; R Boon; R Saltzman
Journal: Ann Intern Med Date: 1995-07-15 Impact factor: 25.391

4. Solid-State Characterization and Compatibility Studies of Penciclovir, Lysine Hydrochloride, and Pharmaceutical Excipients.

Authors: Rafaela Z C Meira; Isabela F B Biscaia; Camila Nogueira; Fabio S Murakami; Larissa S Bernardi; Paulo R Oliveira
Journal: Materials (Basel) Date: 2019-09-27 Impact factor: 3.623

4 in total